Publication Information

{'id': 'https://openalex.org/W2885355639', 'doi': 'https://doi.org/10.1158/1538-7445.am2018-2511', 'title': 'Abstract 2511: ErbB2 receptor levels in patient-derived spheroids vs. solid tumors reveal high ovarian cancer cell plasticity', 'display_name': 'Abstract 2511: ErbB2 receptor levels in patient-derived spheroids vs. solid tumors reveal high ovarian cancer cell plasticity', 'publication_year': 2018, 'publication_date': '2018-07-01', 'ids': {'openalex': 'https://openalex.org/W2885355639', 'doi': 'https://doi.org/10.1158/1538-7445.am2018-2511', 'mag': '2885355639'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2018-2511', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5071374889', 'display_name': 'Mara P. Steinkamp', 'orcid': 'https://orcid.org/0000-0003-1226-9325'}, 'institutions': [{'id': 'https://openalex.org/I169521973', 'display_name': 'University of New Mexico', 'ror': 'https://ror.org/05fs6jp91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I169521973']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mara P. Steinkamp', 'raw_affiliation_strings': ['University of New Mexico, Albuquerque,, NM.'], 'affiliations': [{'raw_affiliation_string': 'University of New Mexico, Albuquerque,, NM.', 'institution_ids': ['https://openalex.org/I169521973']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030541311', 'display_name': 'Ashley Remy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I169521973', 'display_name': 'University of New Mexico', 'ror': 'https://ror.org/05fs6jp91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I169521973']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ashley Remy', 'raw_affiliation_strings': ['University of New Mexico, Albuquerque,, NM.'], 'affiliations': [{'raw_affiliation_string': 'University of New Mexico, Albuquerque,, NM.', 'institution_ids': ['https://openalex.org/I169521973']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051471178', 'display_name': 'Irina Lagutina', 'orcid': 'https://orcid.org/0000-0001-9538-4008'}, 'institutions': [{'id': 'https://openalex.org/I169521973', 'display_name': 'University of New Mexico', 'ror': 'https://ror.org/05fs6jp91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I169521973']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Irina Lagutina', 'raw_affiliation_strings': ['University of New Mexico, Albuquerque,, NM.'], 'affiliations': [{'raw_affiliation_string': 'University of New Mexico, Albuquerque,, NM.', 'institution_ids': ['https://openalex.org/I169521973']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103577721', 'display_name': 'Carolyn Y. Muller', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I169521973', 'display_name': 'University of New Mexico', 'ror': 'https://ror.org/05fs6jp91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I169521973']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Carolyn Y. Muller', 'raw_affiliation_strings': ['University of New Mexico, Albuquerque,, NM.'], 'affiliations': [{'raw_affiliation_string': 'University of New Mexico, Albuquerque,, NM.', 'institution_ids': ['https://openalex.org/I169521973']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045407180', 'display_name': 'Diane S. Lidke', 'orcid': 'https://orcid.org/0000-0001-8533-6029'}, 'institutions': [{'id': 'https://openalex.org/I169521973', 'display_name': 'University of New Mexico', 'ror': 'https://ror.org/05fs6jp91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I169521973']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Diane S. Lidke', 'raw_affiliation_strings': ['University of New Mexico, Albuquerque,, NM.'], 'affiliations': [{'raw_affiliation_string': 'University of New Mexico, Albuquerque,, NM.', 'institution_ids': ['https://openalex.org/I169521973']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5043496898', 'display_name': 'Bridget S. Wilson', 'orcid': 'https://orcid.org/0000-0002-3775-4450'}, 'institutions': [{'id': 'https://openalex.org/I169521973', 'display_name': 'University of New Mexico', 'ror': 'https://ror.org/05fs6jp91', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I169521973']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bridget S. Wilson', 'raw_affiliation_strings': ['University of New Mexico, Albuquerque,, NM.'], 'affiliations': [{'raw_affiliation_string': 'University of New Mexico, Albuquerque,, NM.', 'institution_ids': ['https://openalex.org/I169521973']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 62}, 'biblio': {'volume': '78', 'issue': '13_Supplement', 'first_page': '2511', 'last_page': '2511'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9828, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9828, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.9817, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12996', 'display_name': 'Cancer Research and Treatments', 'score': 0.9649, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/erbb', 'display_name': 'ErbB', 'score': 0.56502897}, {'id': 'https://openalex.org/keywords/erbb3', 'display_name': 'ERBB3', 'score': 0.5031428}], 'concepts': [{'id': 'https://openalex.org/C2780427987', 'wikidata': 'https://www.wikidata.org/wiki/Q172341', 'display_name': 'Ovarian cancer', 'level': 3, 'score': 0.81539035}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.61933506}, {'id': 'https://openalex.org/C2779251935', 'wikidata': 'https://www.wikidata.org/wiki/Q5385089', 'display_name': 'ErbB', 'level': 3, 'score': 0.56502897}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.549197}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.52142024}, {'id': 'https://openalex.org/C115456853', 'wikidata': 'https://www.wikidata.org/wiki/Q17917132', 'display_name': 'ERBB3', 'level': 4, 'score': 0.5031428}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.4618842}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.42621478}, {'id': 'https://openalex.org/C2779984678', 'wikidata': 'https://www.wikidata.org/wiki/Q2145898', 'display_name': 'Response Evaluation Criteria in Solid Tumors', 'level': 4, 'score': 0.42550546}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.40070495}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.38156316}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.33254427}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.21171144}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.20532796}, {'id': 'https://openalex.org/C2778822529', 'wikidata': 'https://www.wikidata.org/wiki/Q1951525', 'display_name': 'Progressive disease', 'level': 3, 'score': 0.07986975}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2018-2511', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.78, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2276082140', 'https://openalex.org/W2117780766', 'https://openalex.org/W2108209940', 'https://openalex.org/W2090622449', 'https://openalex.org/W2058634839', 'https://openalex.org/W2043728488', 'https://openalex.org/W1991858733', 'https://openalex.org/W1975824828', 'https://openalex.org/W1969091416', 'https://openalex.org/W1964572586'], 'abstract_inverted_index': {'Abstract': [0], 'Although': [1], 'ErbB': [2, 127, 230, 397], 'receptors': [3, 15, 52], 'are': [4, 28, 46, 102, 270, 280], 'often': [5], 'expressed': [6], 'in': [7, 30, 35, 72, 106, 159, 264, 305, 328, 364, 370, 374, 430], 'primary': [8, 151], 'ovarian': [9, 107, 118, 152, 216, 265, 438], 'tumors,': [10], 'targeted': [11, 61, 259, 398], 'therapy': [12], 'against': [13], 'these': [14, 51, 70, 186], 'has': [16], 'been': [17], 'minimally': [18], 'successful.': [19], 'Since': [20, 99], 'therapies': [21, 62, 71, 260, 399], 'typically': [22], 'target': [23], 'EGFR': [24], 'or': [25, 379], 'ErbB2': [26, 157, 193, 206, 258, 281, 427], 'that': [27, 92, 155, 257], 'present': [29], '25-35%': [31], 'of': [32, 58, 116, 150, 177, 215, 239, 253, 297, 349, 388, 445], 'cases,': [33], 'variability': [34], 'receptor': [36, 128, 210, 231, 241, 428], 'expression': [37, 211], 'among': [38], 'patients': [39, 120, 269], 'may': [40, 63, 235, 261], 'mask': [41], 'effects.': [42], 'ErbB3': [43, 240, 291], 'and': [44, 124, 180, 248, 316, 339, 367, 390], 'ErbB4': [45, 289], 'more': [47, 80], 'ubiquitous,': [48], 'but': [49, 76, 382], 'targeting': [50], 'is': [53, 256], 'less': [54], 'common.': [55], 'The': [56], 'timing': [57], 'treatment': [59, 387], 'with': [60, 167, 273, 377, 384, 396], 'also': [64, 192], 'be': [65, 79, 236, 262, 288], 'crucial.': [66], 'Clinical': [67], 'trials': [68], 'test': [69], 'recurrent': [73], 'platinum-resistant': [74], 'disease,': [75], 'they': [77, 220], 'might': [78], 'effective': [81, 263], 'at': [82], 'preventing': [83], 'recurrence': [84], 'after': [85], 'surgery': [86, 123], 'by': [87, 130], 'eliminating': [88], 'free-floating': [89, 223], 'cancer': [90, 100, 119, 133, 153, 168, 217, 266, 439], 'spheroids': [91, 101, 111, 134, 169, 224, 247, 279, 432], 'give': [93], 'rise': [94], 'to': [95, 170, 204, 225, 287, 320, 335, 345], 'new': [96], 'solid': [97, 178, 196, 226, 249, 284, 434], 'tumors.': [98, 227, 250], 'not': [103], 'routinely': [104], 'characterized': [105], 'cancer,': [108], 'we': [109, 293], 'isolated': [110], 'from': [112, 135, 147, 185, 198, 222], 'the': [113, 148, 199, 213, 229, 295, 313, 356, 385, 446], 'malignant': [114, 181], 'ascites': [115, 371], '22': [117], 'undergoing': [121], 'cytoreductive': [122], 'analyzed': [125], 'their': [126], 'signatures': [129], 'immunofluorescence.': [131], 'Surprisingly,': [132], 'nearly': [136], 'all': [137], 'samples': [138], '(85%)': [139], 'were': [140, 156, 191, 310, 318], 'positive': [141, 158], 'for': [142, 449], 'ErbB2.': [143], 'This': [144, 208], 'differs': [145], 'markedly': [146], '35%': [149], 'tumors': [154, 179, 197, 285, 317, 352, 435], 'our': [160, 306], 'previous': [161], 'study.': [162], 'NSG': [163], 'mice': [164], 'injected': [165, 340], 'intraperitoneally': [166], 'model': [171], 'disseminated': [172], 'disease': [173], 'developed': [174], 'a': [175, 298, 368], 'combination': [176], 'ascites.': [182], 'Spheroids': [183], 'obtained': [184], 'patient-derived': [187, 431], 'xenograft': [188], '(PDX)': [189], 'models': [190, 201], 'positive.': [194], 'However,': [195], 'PDX': [200, 329], 'showed': [202], 'little': [203], 'no': [205, 244], 'labeling.': [207], 'altered': [209], 'demonstrates': [212], 'plasticity': [214, 441], 'cells': [218, 404], 'as': [219], 'transition': [221], 'In': [228], 'family,': [232], 'this': [233, 254], 'change': [234, 245], 'ErbB2-specific.': [237], 'Analysis': [238], 'status': [242], 'found': [243], 'between': [246], 'One': [251], 'implication': [252], 'finding': [255], 'cases': [267], 'where': [268], 'optimally': [271], 'debulked': [272], 'only': [274], 'microscopic': [275], 'residual': [276], 'disease.': [277], 'Because': [278], 'positive,': [282, 292], 'while': [283, 405], 'tend': [286], 'and/or': [290], 'explored': [294], 'effect': [296], 'pan-ErbB': [299], 'inhibitor,': [300], 'afatinib,': [301], 'on': [302, 355], 'tumor': [303, 326, 365], 'burden': [304, 327, 348, 366], 'mouse': [307], 'models.': [308], 'Cells': [309], 'inoculated': [311], 'into': [312], 'peritoneal': [314], 'cavity': [315], 'allowed': [319], 'develop': [321], 'before': [322], 'treatment.': [323], 'To': [324], 'measure': [325], 'models,': [330], 'anti-HLA-ABC': [331], 'antibody': [332], 'was': [333, 353, 372], 'conjugated': [334], 'CF750': [336], 'near-infrared': [337], 'dye': [338], 'IP': [341], '24': [342], 'hours': [343], 'prior': [344], 'imaging.': [346], 'Tumor': [347], 'fluorescently': [350], 'labeled': [351], 'measured': [354], 'IVIS': [357], 'Spectrum': [358], 'using': [359], 'fluorescence': [360], 'tomography.': [361], 'A': [362], 'decrease': [363], 'reduction': [369], 'seen': [373], 'groups': [375], 'treated': [376], 'afatinib': [378, 389], 'paclitaxel': [380], 'alone,': [381], 'particularly': [383], 'combined': [386], 'paclitaxel.': [391], 'Supplementing': [392], 'current': [393], 'first-line': [394], 'treatments': [395], 'could': [400], 'potentially': [401], 'destroy': [402], 'chemoresistant': [403], 'limiting': [406], 'increased': [407], 'toxicity.': [408], 'Citation': [409], 'Format:': [410], 'Mara': [411], 'P.': [412], 'Steinkamp,': [413], 'Ashley': [414], 'Remy,': [415], 'Irina': [416], 'Lagutina,': [417], 'Carolyn': [418], 'Y.': [419], 'Muller,': [420], 'Diane': [421], 'S.': [422, 425], 'Lidke,': [423], 'Bridget': [424], 'Wilson.': [426], 'levels': [429], 'vs.': [433], 'reveal': [436], 'high': [437], 'cell': [440], '[abstract].': [442], 'In:': [443], 'Proceedings': [444], 'American': [447], 'Association': [448], 'Cancer': [450, 463], 'Research': [451], 'Annual': [452], 'Meeting': [453], '2018;': [454], '2018': [455], 'Apr': [456], '14-18;': [457], 'Chicago,': [458], 'IL.': [459], 'Philadelphia': [460], '(PA):': [461], 'AACR;': [462], 'Res': [464], '2018;78(13': [465], 'Suppl):Abstract': [466], 'nr': [467], '2511.': [468]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2885355639', 'counts_by_year': [], 'updated_date': '2024-12-12T01:29:43.559879', 'created_date': '2018-08-22'}